HC Wainwright & Co. Initiates Coverage On ImageneBio with Buy Rating, Announces Price Target of $28
HC Wainwright & Co. analyst Arthur He initiates coverage on ImageneBio (NASDAQ:IMA) with a Buy rating and announces Price Target of $28.
Filings · News reference
ImageneBio Files Prospectus For Offering $200M Mixed Shelf
https://www.sec.gov/Archives/edgar/data/1835579/000119312526335213/d150354ds3.htm
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
ImageneBio Q2 EPS $(0.63) Beats $(1.05) Estimate
ImageneBio (NASDAQ:IMA) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(1.05) by 40 percent.
8-K filing — ImageneBio, Inc. (IMA)
Filed: 2026-08-05 AccNo: 0001193125-26-333912 Size: 256 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits